
Clinical laboratory tests are critical to how clinicians screen for disease, diagnose conditions, guide treatment, and monitor outcomes for patients with diabetes, cancer, heart disease, and more.
The problem. The Protecting Access to Medicare Act (PAMA) of 2014 was meant to align Medicare lab payments with private-market rates. In practice, the first round of data collection captured data from fewer than 1 percent of laboratories. The result was artificially low rates and $3.8 billion in cuts in just three years. Congress has repeatedly stepped in to delay further cuts, but short-term patches leave laboratories and patients facing recurring uncertainty.
The solution. The bipartisan, bicameral Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (H.R. 5269 / S. 2761) would fix the underlying problem. It would:
- Use comprehensive paid-claims data from an independent, not-for-profit commercial payer database to set rates for widely available tests, rather than relying on incomplete laboratory reporting.
- Reduce the data-reporting burden on laboratories and CMS.
- Exclude Medicaid managed care rates, which are not truly market-based.
- Freeze rates and cancel pending cuts during implementation, then limit payment reductions to 5 percent per year once the new system is fully in place.
The RESULTS Act is endorsed by the GOP Doctors Caucus and the Problem Solvers Caucus, and it has more than 120 bipartisan cosponsors. AdvaMed is an active member of the Clinical Labs Coalition and is working with partners across health care to advance the bill. Stable, accurate lab payment protects patient access today. It also supports the investment needed to bring the next generation of diagnostics to patients.
To learn more or to urge Congress to act, visit StopLabCuts.org.
Hear Patient Stories
The Story of Medtech empowers patients to share their experiences with medical technology in an effort to educate, inspire, and create community.